Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · Real-Time Price · USD
2.990
-0.130 (-4.17%)
Sep 9, 2026, 4:00 PM EDT - Market closed
Perspective Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jun '22 Jun 30, 2022 |
Net Income | -116.43 | -103.12 | -79.28 | -46.51 | -10.76 | -7.27 |
Depreciation & Amortization | 4.05 | 3.24 | 2.3 | 0.71 | 0.32 | 0.28 |
Other Amortization | 0.01 | 0.01 | 0.01 | 0.01 | 0 | 0.01 |
Loss (Gain) From Sale of Assets | - | - | 0.03 | 0.02 | 0.31 | - |
Asset Writedown & Restructuring Costs | - | - | 24.06 | - | - | - |
Loss (Gain) From Sale of Investments | -2.11 | -2.72 | -0.61 | - | - | - |
Stock-Based Compensation | 10.06 | 8.97 | 5.22 | 3.14 | 0.98 | 1.09 |
Other Operating Activities | 9.35 | 9.46 | -2.06 | -2.24 | -0.22 | 0 |
Change in Accounts Receivable | -0.04 | 0.11 | 1.05 | 0.2 | 0.28 | 0.41 |
Change in Inventory | - | - | - | - | -2 | -2.67 |
Change in Accounts Payable | 1.11 | 0.15 | 1.89 | 1.57 | 0.69 | 0.24 |
Change in Unearned Revenue | - | -1.4 | 28 | - | - | - |
Change in Other Net Operating Assets | 0.94 | 2.82 | 0.86 | 0.79 | -0.03 | 0.18 |
Operating Cash Flow | -93.07 | -82.48 | -18.29 | -36.91 | -10.4 | -7.71 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jun '22 Jun 30, 2022 |
Capital Expenditures | -28.12 | -12.75 | -54.41 | -1.07 | -0.28 | -0.27 |
Sale of Property, Plant & Equipment | - | - | 0.34 | - | - | - |
Cash Acquisitions | - | - | - | 2.7 | - | - |
Investment in Securities | -23.77 | 54.11 | -164.78 | 22.76 | -22.69 | - |
Other Investing Activities | -0.11 | -0.14 | -0.07 | -0.02 | -6.02 | -0.02 |
Investing Cash Flow | -52.01 | 41.23 | -218.93 | 24.37 | -28.99 | -0.28 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jun '22 Jun 30, 2022 |
Long-Term Debt Repaid | - | -0.05 | -0.05 | -0.07 | - | - |
Net Debt Issued (Repaid) | -0.05 | -0.05 | -0.05 | -0.07 | - | - |
Issuance of Common Stock | 164.77 | 10.36 | 289.43 | 0.92 | 0.03 | 0.06 |
Other Financing Activities | - | - | - | -0.07 | - | - |
Financing Cash Flow | 164.71 | 10.31 | 289.39 | 0.79 | 0.03 | 0.06 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jun '22 Jun 30, 2022 |
Net Cash Flow | 19.64 | -30.95 | 52.16 | -11.76 | -39.36 | -7.94 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -121.19 | -95.23 | -72.71 | -37.99 | -10.68 | -7.98 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -29630.07% | -10772.96% | -5000.55% | -2648.88% | -197.28% | - |
Free Cash Flow Per Share | -1.30 | -1.29 | -1.13 | -1.42 | -0.75 | -0.56 |
Levered Free Cash Flow | -69.43 | -60.37 | -83.66 | -8.54 | - | -2.73 |
Unlevered Free Cash Flow | -69.24 | -60.14 | -83.63 | -8.49 | - | -2.73 |